Prevalence of Novel Myositis Autoantibodies in a Large Cohort of Patients with Interstitial Lung Disease
Connective tissue diseases (CTDs) are an important secondary cause of interstitial lung disease (ILD). If a CTD is suspected, clinicians are recommended to perform autoantibody testing, including for myositis autoantibodies. In this study, the prevalence and clinical associations of novel myositis a...
Main Authors: | Sofia A. Moll, Mark G. J. P. Platenburg, Anouk C. M. Platteel, Adriane D. M. Vorselaars, Montse Janssen Bonàs, Claudia Roodenburg-Benschop, Bob Meek, Coline H. M. van Moorsel, Jan C. Grutters |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/9/2944 |
Similar Items
-
Myositis interstitial lung disease and autoantibodies
by: Shire Chaudhry, et al.
Published: (2023-06-01) -
Management of Myositis-Associated Interstitial Lung Disease
by: Tomoyuki Fujisawa
Published: (2021-04-01) -
High-Resolution CT Findings of Myositis-Related Interstitial Lung Disease
by: Ryoko Egashira
Published: (2021-07-01) -
Dissociating Autoantibody Responses against Ro52 Antigen in Patients with Anti-Synthetase or Anti-MDA5 Antibodies
by: Akira Yoshida, et al.
Published: (2023-12-01) -
Clinical features and outcomes of patients with myositis associated-interstitial lung disease
by: Theodoros Karampitsakos, et al.
Published: (2023-01-01)